Vemurafenib acts as an aryl hydrocarbon receptor antagonist: Implications for inflammatory cutaneous adverse events.
Hawerkamp HC, Kislat A, Gerber PA, Pollet M, Rolfes KM, Soshilov AA, Denison MS, Momin AA, Arold ST, Datsi A, Braun SA, Oláh P, Lacouture ME, Krutmann J, Haarmann-Stemmann T, Homey B, Meller S.
Hawerkamp HC, et al. Among authors: krutmann j.
Allergy. 2019 Dec;74(12):2437-2448. doi: 10.1111/all.13972. Epub 2019 Sep 3.
Allergy. 2019.
PMID: 31269229
Free PMC article.